Search results
Results from the WOW.Com Content Network
Ropinirole, sold under the brand name Requip among others, is a medication used to treat Parkinson's disease (PD) and restless legs syndrome (RLS). [3] It is taken by mouth. [4] Common side effects include sleepiness, vomiting, and dizziness. [4] Serious side effects may include pathological gambling, low blood pressure with standing and ...
Still sold in the US Levamisole (Ergamisol) 1999 US Still used as veterinary drug and as a human antihelminthic in many markets; listed on the WHO List of Essential Medicines. In humans, it was used to treat melanoma before it was withdrawn for agranulocytosis. [29] [30] [31] Levomethadyl acetate: 2003 US Cardiac arrhythmias and cardiac arrest. [2]
A category for drugs withdrawn from the market after marketing commenced for any reason (voluntarily or involuntarily). For drug candidates that were abandoned prior to being marketed due to side effects, lack of efficacy, superior competitors, or other reasons, see Category:Abandoned drugs
Americans stand to lose between $46 billion and $78 billion in spending power each year on products including ... telling a gathering last month at the Economic Club of Chicago that "the countries ...
The U.S. Food and Drug Administration (FDA) announced that it plans to ban products containing phenylephrine, an ingredient found in many over-the-counter (OTC) oral cold and flu medications.
Alas, the fan-favorite grocery staple was short-lived, joining the ranks of dearly departed Trader Joe's products at the end of 2022. Amazon Chocolate Chip Cocoa Meringues
This is a list of defunct (mainly American) consumer brands which are no longer made and usually no longer mass-marketed to consumers. Brands in this list may still be made, but are only made in modest quantities and/or limited runs as a nostalgic or retro style item.
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each month, an industry group told the U.S. drugs regulator in a letter ...